ORTHOBOND CORPORATION

Web Site Results

Welcome to Orthobond

[ About us | Technology | Investors | Contact us ] Welcome to Orthobond Orthobond is a privately held medical company developing surface modification technology that can be applied to virtually any synthetic material to produce a desired

Orthobond - Self-Assembled Monolayer Phosphonate

[ About us | Technology | Investors | Contact us ] SAMP Osteoconductivity Bioresistance Anti-Infective Self-Assembled Monolayer of Phosphonate ("SAMP") Orthobond's technology is based on Prof. Jeffrey Schwartz's breakthrough invention of self-assembled monolayers

Bioresistance

[ About us | Technology | Investors | Contact us ] SAMP Osteoconductivity Bioresistance Anti-Infective Bioresistance Bioresistant devices are desirable in applications where limiting biological reactions to implants is beneficial to patient outcomes. Tissue integration

Orthobond - Our Technology

[ About us | Technology | Investors | Contact us ] SAMP Osteoconductivity Bioresistance Anti-Infective Our Technology Manipulating the interface between synthetic material and the human body has presented risks to patients and challenges to

Orthobond - Investor Relations

[ About us | Technology | Investors | Contact us ] Investor Relations Orthobond is a privately-funded corporation. In 2005, the Comany closed a seed round of $2.5 million. Subsequently, Orthobond has raised another $1.5 million in convertible debt